Fluorescent in Situ Hybridization (FISH) Market

Fluorescent in Situ Hybridization (FISH) Market Size, Share, Trends, Growth, and Industry Analysis, By Type (RNA, and DNA), By Application (Genetic Diseases, and Cancer Diagnosis), By Technology (Flow FISH, and Q FISH), By End-use (Clinical, and Research), Regional Analysis and Forecast 2032.

Medical Devices | October 2024 | Report ID: EMR00931 | Pages: 251

Fluorescent in Situ Hybridization (FISH) Market Trend

Global Fluorescent in Situ Hybridization (FISH) Market size was USD 1.92 billion in 2023 and the market is projected to touch USD 3.18 billion by 2032, at a CAGR of 6.5% during the forecast period.

 

The global fluorescent in situ hybridization market (FISH) is a specialized technique that is commonly used for finding and mapping specific DNA sequences on chromosomes. This method finds its application in genetic research, cancer diagnosis and prenatal tests aimed at identifying chromosomal abnormalities and mutations within certain genes. FISH plays an important role in understanding genetic disorders as well as developing personalized treatment plans. Because of the increasing demand for early disease diagnosis, especially in cancer research, this market has continued to grow. Technological advancements and increased awareness about hereditary diseases are also contributing factors. However, growth can be hampered because of high costs associated with FISH testing and need for trained personnel. Even so, the market is predicted to expand with time since there is an increase in significance of genetic analysis on health care systems.

 

Fluorescent in Situ Hybridization (FISH) Report Scope and Segmentation.

Report Attribute

Details

Estimated Market Value (2023)

USD 1.92 Billion

Projected Market Value (2032)

USD 3.18 Billion

Base Year

2023

Historical Year

2018-2022

Forecast Years

2024 – 2032

Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Based on By Type, By Application, By Technology, By End-use, & Region.

Segments Covered

By Type, By Application, By Technology, By End-use, & By Region.

Forecast Units

Value (USD Million or Billion), and Volume (Units)

Quantitative Units

Revenue in USD million/billion and CAGR from 2024 to 2032.

Regions Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others.

Report Coverage

Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis.

Delivery Format

Delivered as an attached PDF and Excel through email, according to the purchase option.

 

Dynamic Insights

As high incidence of genetic disorders and cancers continues to be experienced, there is increasing need for accurate diagnostic instruments hence propelling demand in Global Fluorescent in Situ Hybridization (FISH) market. With improvements in technology, FISH is gaining about precision and efficiency that make it almost always a desirable option for genetic analysis. More research activities are supporting it while also pushing for personalized medicine serves as drivers of the market growth. On the contrary, costs of HPV models (including Vectra equipment) apart from the requirement of professionals who can administer tests have been some limiting factors. Therefore, this situation slows down openings within this realm and hampers overall growth patterns. Continued advancements in technology combined with early diagnosis of their various diseases will continue to maintain an upward trajectory for this sector even with its challenges.

 

Drivers Insights

  • Increasing Prevalence of Genetic Disorders and Cancers

The FISH market is greatly influenced by the increasing occurrence rates of cancer diagnoses and genetic disorders all over the world. There is therefore an imminent need to develop high-tech diagnostic tools that allow for accurate and timely information as genetic conditions continue to become more prevalent with time. FISH is very important in diagnosing several genetic disorders like Downs syndrome and some types of cancer such as leukaemia or breast cancer because it can identify specific sequences of DNA or chromosomal aberrations. This progress in market growth has come about due to rising demand for early and precise detection which encourages people to embrace FISH technology.

  • Technological Advancements

The health industry has benefited immensely from continuous advancements in the Fish technology that amplifies the diagnostic capability and precision of this method. Some of the recent innovations in this area include high-definition imaging, automation and improved fluorescent probes which have made it easier to use and efficient even in low resource settings like hospitals. The result is an increase in accuracy and versatility, making it applicable in various sectors such as medicine or biophysics research. The ability to carry out more complex genetic analyses allows us to meet the increasing need for accurate diagnostic devices for personalized medicine driving hence expansion of market share.

 

Restraints Insights

  • High Cost of Equipment and Reagents

The costliness of FISH devices and their reagents is one of the major constraints in the FISH market. The price of sophisticated FISH systems and continuous purchase of fluorescent probes and other consumables can be heavy. Consequently, higher rates can restrict the use of FISH technology particularly in developing areas and small labs that have limited funds. It follows that this expensiveness can hinder mass production and propagate development of the market as a whole.

  • Need for Specialized Training and Expertise

FISH technology needs professional training and expertise for precise functioning and result interpretation. Complexity of the process plus its need for competent individuals can be a big challenge. Labs and hospitals must set aside funds for training programs as well as skilled personnel to effectively use FISH technology. Such limitations could hinder adoption of FISH, especially in areas that lack trained personnel hence impeding the growth of the market.

 

Opportunities Insights

  • Growing Focus on Personalized Medicine

Increased focus on personalized medicine presents a huge opportunity for the FISH market. Personalized medicine depends on right genetic information to customize treatments for individual patients making it necessary to have accurate diagnostic tools. In this regard, FISH technology gives crucial insights into genetic abnormalities and mutations that can be used in coming up with personalized treatment plans. Therefore, as personalized medicine develops, demand for FISH technology will increase hence creating great potential for the market.

 

Segment Analysis

  • By Type

By Type, Fluorescent in Situ Hybridization (FISH) Market, is segmented into RNA and DNA. The RNA segment involves using FISH to detect specific RNA sequences. For this reason, it is important in the studies of gene expression and research into their disorders concerned with RNA (disorders). This type of FISH is generally applied in research to unravel the process behind gene activity and its regulation. DNA FISH deals with finding DNA sequences or chromosomal abnormalities. In clinical diagnostics, this method can be employed for identifying any mutations in a genome that can lead to diseases such as cancers or genetic syndromes caused by aberration(s) within chromosomes. Both types of FISH play essential roles in genetic research as well as in clinical diagnostics that have been contributing towards growth of market by focusing on various aspects regarding genetical analyse.

  • By Application

By application, the FISH market is segmented into genetic diseases and cancer diagnosis. The applications of genetic diseases include FISH technology to detect chromosomal abnormalities and hereditary mutations seen in disorders such as Down syndrome, cystic fibrosis and muscular dystrophy. It is an important part of early diagnosis and treatment of genetic diseases. As opposed to this, cancer diagnosing section employs FISH for detecting genetic changes linked to different types of cancers such as leukaemia, breast cancer as well as prostate cancer. FISH provides assistance in identifying distinct types of genetic variations which are essential for precise identification, prediction and customized therapies against cancer. The two uses play a significant role in promoting the adoption of FISH technology in healthcare practices or research laboratories.

  • By Technology

By Technology, the FISH market is also segmented into Flow FISH and Q FISH. In flow FISH, flow cytometry is used to analyse and sort cells through his use FISH methodology. Flow FISH is advantageous for rapid screening and research based on a larger scale study. For accurate measurements of fluorescent signals that can be used to quantify particular DNA sequences or chromosomal regions, Q FISH (Quantitative Fluorescence in Situ Hybridization). This method allows detailed genetic analyses like monitoring chromosomal abnormalities and gene copy numbers. The two methods extend the options offered by FISH technology which meet different requirements in genetic research and clinical diagnostics.

  • By End-use

By end-use, the FISH market is segmented into clinical and research. FISH technology has been implemented in clinical diagnosis of genetic disorders and cancers, guiding treatment options, as well as monitoring disease progression. In clinical practice, a high degree of accuracy and reliability is needed for suitable management of patients. In research laboratories, FISH is used to investigate genetic mechanisms, validate the roles played by genes themselves and study chromosomes. Research applications spur new ideas and knowledge on genetic and cellular processes. The integration of clinical and research uses of this technology ensures that it meets not only practical requirements but also those related to scientific exploration thus propelling global market expansion.

 

Regional Analysis

The Global Fluorescent in Situ Hybridization (FISH) Market is witnessing a notable rise in different parts of the world. North America tops the chart due to its advanced health systems, high rates of adoption of FISH technology, as well as robust research and development activities. Europe comes second, where increased research initiatives and high awareness about genetic disorders propel it. The Asia-Pacific region on the other hand is undergoing rapid growth supported by increasing investments in healthcare, improved medical facilities, rise in incidences of genetic diseases and cancer. Also, Latin America and Middle East & Africa are showing slow but steady growth towards this end with their focus on accurate diagnosis driven by expanding healthcare facilities. North America and Europe hold sway but expect to see substantial growth in Asia-Pacific over next years due to development of health sector there as well as nice demand for advanced diagnostics.

 

Competitive Landscape

The Global FISH Market is identified by the presence of many key players and an emphasis on technological innovation and strategic collaborations. The major players in this market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories and Thermo Fisher Scientific which offer a range of advanced products for FISH purposes. They employ their wide-ranging R&D capabilities to create state-of-the-art technologies for new product lines. Besides these industry leaders are several other notable competitors such as F. Hoffmann-La Roche and Kreatech Biotechnology who also provide specialized FISH solutions contributing to competition among different market players. It is not uncommon for rival firms to engage in strategic efforts like mergers & acquisitions or joint ventures in order to grow their hold on the industry with better technology. One way that the competitive landscape is made more intense is through the improvement of existing technologies and new applications or methods that force companies into innovating and adjusting to changes within customer preferences. In this way, the government forces a better understanding of FISH technology while increasing its level of availability for both clinical diagnosis and research.

List of Key Players:

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd
  • Kreatech Biotechnology
  • PerkinElmer Inc.
  • Leica Biosystems
  • GE Healthcare
  • Nikon Instruments Inc.

 

Recent Developments:

  • Dec 2022, there was a clinical trial that was completed and that described in retrospective the rate of tumours FISH (Fluorescence in Situ Hybridization) for perivascular epithelioid tumours which were carried out. The trial was sponsored by University Hospital, Strasbourg, France.

 

Global Fluorescent in Situ Hybridization (FISH) Report Segmentation:

ATTRIBUTE

DETAILS

By Type

  • RNA
  • DNA

By Application

  • Genetic Diseases
  • Cancer Diagnosis

By Technology

  • Flow FISH
  • and Q FISH

By End-use

  • Clinical
  • Research

By Geography

  • North America (USA, and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Russia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Customization Scope

  • Available upon request

Pricing

  • Available upon request

 

Objectives of the Study

The objectives of the study are summarized in 5 stages. They are as mentioned below:

  • Global Fluorescent in Situ Hybridization (FISH) size and forecast: To identify and estimate the market size for global Fluorescent in Situ Hybridization (FISH) market segmented By Type, By Application, By Technology, By End-use, and by region. Also, to understand the consumption/ demand created by consumers between 2024 and 2032.
  • Market Landscape and Trends: To identify and infer the drivers, restraints, opportunities, and challenges for global Fluorescent in Situ Hybridization (FISH)
  • Market Influencing Factors: To find out the factors which are affecting the market of global Fluorescent in Situ Hybridization (FISH) among consumers.
  • Company Profiling:  To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company's past 2-3 years with segmental and regional revenue breakdowns, product offering, recent developments, SWOT analysis, and key strategies.

Request For Table of Content

Research Methodology

Our research methodology has always been the key differentiating reason which sets us apart in comparison from the competing organizations in the industry. Our organization believes in consistency along with quality and establishing a new level with every new report we generate; our methods are acclaimed and the data/information inside the report is coveted. Our research methodology involves a combination of primary and secondary research methods. Data procurement is one of the most extensive stages in our research process. Our organization helps in assisting the clients to find the opportunities by examining the market across the globe coupled with providing economic statistics for each and every region.  The reports generated and published are based on primary & secondary research. In secondary research, we gather data for global Market through white papers, case studies, blogs, reference customers, news, articles, press releases, white papers, and research studies. We also have our paid data applications which includes hoovers, Bloomberg business week, Avention, and others.

Data Collection

Data collection is the process of gathering, measuring, and analyzing accurate and relevant data from a variety of sources to analyze market and forecast trends. Raw market data is obtained on a broad front. Data is continuously extracted and filtered to ensure only validated and authenticated sources are considered. Data is mined from a varied host of sources including secondary and primary sources.

Primary Research

After the secondary research process, we initiate the primary research phase in which we interact with companies operating within the market space. We interact with related industries to understand the factors that can drive or hamper a market. Exhaustive primary interviews are conducted. Various sources from both the supply and demand sides are interviewed to obtain qualitative and quantitative information for a report which includes suppliers, product providers, domain experts, CEOs, vice presidents, marketing & sales directors, Type & innovation directors, and related key executives from various key companies to ensure a holistic and unbiased picture of the market. 

Secondary Research

A secondary research process is conducted to identify and collect information useful for the extensive, technical, market-oriented, and comprehensive study of the market. Secondary sources include published market studies, competitive information, white papers, analyst reports, government agencies, industry and trade associations, media sources, chambers of commerce, newsletters, trade publications, magazines, Bloomberg BusinessWeek, Factiva, D&B, annual reports, company house documents, investor presentations, articles, journals, blogs, and SEC filings of companies, newspapers, and so on. We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

Top-Down Approach & Bottom-Up Approach

In the top – down approach, the Global Batteries for Solar Energy Storage Market was further divided into various segments on the basis of the percentage share of each segment. This approach helped in arriving at the market size of each segment globally. The segments market size was further broken down in the regional market size of each segment and sub-segments. The sub-segments were further broken down to country level market. The market size arrived using this approach was then crosschecked with the market size arrived by using bottom-up approach.

In the bottom-up approach, we arrived at the country market size by identifying the revenues and market shares of the key market players. The country market sizes then were added up to arrive at regional market size of the decorated apparel, which eventually added up to arrive at global market size.

This is one of the most reliable methods as the information is directly obtained from the key players in the market and is based on the primary interviews from the key opinion leaders associated with the firms considered in the research. Furthermore, the data obtained from the company sources and the primary respondents was validated through secondary sources including government publications and Bloomberg.

Market Analysis & size Estimation

Post the data mining stage, we gather our findings and analyze them, filtering out relevant insights. These are evaluated across research teams and industry experts. All this data is collected and evaluated by our analysts. The key players in the industry or markets are identified through extensive primary and secondary research. All percentage share splits, and breakdowns have been determined using secondary sources and verified through primary sources. The market size, in terms of value and volume, is determined through primary and secondary research processes, and forecasting models including the time series model, econometric model, judgmental forecasting model, the Delphi method, among Flywheel Energy Storage. Gathered information for market analysis, competitive landscape, growth trends, product development, and pricing trends is fed into the model and analyzed simultaneously.

Quality Checking & Final Review

The analysis done by the research team is further reviewed to check for the accuracy of the data provided to ensure the clients’ requirements. This approach provides essential checks and balances which facilitate the production of quality data. This Type of revision was done in two phases for the authenticity of the data and negligible errors in the report. After quality checking, the report is reviewed to look after the presentation, Type and to recheck if all the requirements of the clients were addressed.

Frequently Asked Questions

Global Fluorescent in Situ Hybridization (FISH) forecast period is 2024 - 2032.
According to global Fluorescent in Situ Hybridization (FISH) research, the market is expected to grow at a CAGR of ~ 6.5% over the next eight years.
The possible segments in global Fluorescent in Situ Hybridization (FISH) are based on By Type, By Application, By Technology, By End-use, & by region.
The expected market size for Global Fluorescent in Situ Hybridization (FISH) is USD 3.19 billion in 2032.
The major players in the market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Kreatech Biotechnology, PerkinElmer Inc., Leica Biosystems, GE Healthcare, and Nikon Instruments Inc.
×

Avail PDF Sample Reports